Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives Average Recommendation of “Moderate Buy” from Brokerages

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has been given a consensus recommendation of “Moderate Buy” by the nine brokerages that are covering the firm, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $50.39.

Several equities research analysts recently commented on ACHC shares. Bank of America decreased their price objective on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating on the stock in a research report on Friday, February 28th. Barclays downgraded shares of Acadia Healthcare from an “overweight” rating to an “equal weight” rating and reduced their price target for the company from $43.00 to $35.00 in a report on Friday, February 28th. KeyCorp cut their price objective on Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating for the company in a research report on Monday, March 3rd. StockNews.com lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, January 6th. Finally, Guggenheim started coverage on Acadia Healthcare in a report on Wednesday, April 9th. They issued a “buy” rating and a $36.00 price target for the company.

Acadia Healthcare Price Performance

Shares of NASDAQ ACHC opened at $23.40 on Thursday. The company’s fifty day moving average is $28.35 and its two-hundred day moving average is $38.06. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The firm has a market capitalization of $2.16 billion, a P/E ratio of 7.67, a PEG ratio of 1.46 and a beta of 1.13. Acadia Healthcare has a one year low of $20.36 and a one year high of $82.41.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. Tidal Investments LLC boosted its position in Acadia Healthcare by 7.9% during the 3rd quarter. Tidal Investments LLC now owns 4,664 shares of the company’s stock worth $296,000 after purchasing an additional 340 shares during the period. Franklin Resources Inc. boosted its position in shares of Acadia Healthcare by 273.1% in the third quarter. Franklin Resources Inc. now owns 105,228 shares of the company’s stock worth $6,673,000 after buying an additional 77,027 shares during the period. Oddo BHF Asset Management Sas purchased a new stake in shares of Acadia Healthcare during the 3rd quarter valued at about $1,613,000. Principal Financial Group Inc. lifted its position in Acadia Healthcare by 2.1% during the 3rd quarter. Principal Financial Group Inc. now owns 656,889 shares of the company’s stock worth $41,653,000 after acquiring an additional 13,368 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its position in Acadia Healthcare by 17.0% in the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock valued at $198,258,000 after acquiring an additional 454,044 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.